Skip to search formSkip to main contentSkip to account menu

polyvalent pseudomonas vaccine

Known as: PEV-01, pseudomonas vaccine PEV 01 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pseudomonas Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Pilot study into the IgG1 and IgG2 subclass response to polyvalent Pseudomonas vaccine in burned adults.
1984
1984
A new polyvalent pseudomonas vaccine.
A new polyvalent Pseudomonas aeruginosa vaccine consisting of extracts of the 24 serotypes of the Lanyi typing scheme was… 
1983
1983
Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
Patients (746) aged one to 60 years admitted to Safdarjang Hospital with full skin-thickness burns over 5%-70% of their body… 
1983
1983
Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats
Rats were immunized systemically with various doses of the polyvalent Pseudomonas aeruginosa vaccine PEV-01. After a series of… 
1983
1983
Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia.
Three cell wall-derived Pseudomonas aeruginosa vaccines were evaluated for their capacity to provide protection from experimental… 
1983
1983
Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
Highly Cited
1980
Highly Cited
1980
CONTROLLED TRIAL OF PSEUDOMONAS IMMUNOGLOBULIN AND VACCINE IN BURN PATIENTS
1979
1979
Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections
A new polyvalent, cell wall extract, Pseudomonas aeruginosa vaccine (PEV-01), was evaluated by using a guinea pig model of… 
1979
1979
Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine
SUMMARY In two controlled clinical trials of a polyvalent pseudomonas vaccine, vaccinated burned patients showed higher antibody… 
1976
1976
A new Pseudomonas vaccine: Preliminary trial on human volunteers
SUMMARY Fifteen healthy volunteers were given three weekly subcutaneous injections of a new polyvalent Pseudomonas aeruginosa… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)